The Role of Endothelial Dysfunction and Inflammation in Chronic Venous Disease.

[1]  S. Hahn,et al.  Recommendations for the medical management of chronic venous disease: The role of Micronized Purified Flavanoid Fraction (MPFF) , 2017, Phlebology.

[2]  A. Puca,et al.  Rac1 Pharmacological Inhibition Rescues Human Endothelial Dysfunction , 2017, Journal of the American Heart Association.

[3]  K. Książek,et al.  Endovenous Laser Ablation of Varicose Veins Preserves Biological Properties of Vascular Endothelium and Modulates Proinflammatory Agent Profile More Favorably Than Classic Vein Stripping , 2017, BioMed research international.

[4]  J. Raffetto,et al.  Chronic venous disease - Part I: Inflammatory biomarkers in wound healing. , 2016, Biochimica et biophysica acta.

[5]  P. Secchiero,et al.  Oscillatory flow suppression improves inflammation in chronic venous disease. , 2016, The Journal of surgical research.

[6]  S. Desai,et al.  The Impact of Race on Advanced Chronic Venous Insufficiency. , 2016, Annals of vascular surgery.

[7]  J. Tarbell,et al.  The glycocalyx and its significance in human medicine , 2016, Journal of internal medicine.

[8]  G. Geroulakos,et al.  Endogenous pro-thrombotic biomarkers from the arm and leg may not have the same value , 2016, Phlebology.

[9]  G. Geroulakos,et al.  Are Inflammatory Biomarkers Increased in Varicose Vein Blood? , 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[10]  R. Khalil,et al.  Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease , 2015, The Journal of Pharmacology and Experimental Therapeutics.

[11]  M. Kucharzewski,et al.  Effect of Micronized Purified Flavonoid Fraction Therapy on Endothelin-1 and TNF-α Levels in Relation to Antioxidant Enzyme Balance in the Peripheral Blood of Women with Varicose Veins. , 2015, Current vascular pharmacology.

[12]  J. Fareed,et al.  Do blood constituents in varicose veins differ from the systemic blood constituents? , 2015, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[13]  T. Urbanek,et al.  Sulodexide suppresses inflammation in patients with chronic venous insufficiency. , 2015, International angiology : a journal of the International Union of Angiology.

[14]  F. Ponziani,et al.  Biomarkers of low-grade inflammation in primary varicose veins of the lower limbs. , 2015, European review for medical and pharmacological sciences.

[15]  G. Geroulakos,et al.  d-Dimer Levels are Significantly Increased in Blood Taken From Varicose Veins Compared With Antecubital Blood From the Same Patient , 2015, Angiology.

[16]  G. Schmid-Schönbein,et al.  Cellular and molecular basis of Venous insufficiency , 2014, Vascular cell.

[17]  R. Launois,et al.  Linguistic validation of the 20 item-chronic venous disease quality-of-life questionnaire (CIVIQ-20) , 2014, Phlebology.

[18]  J. Raffetto,et al.  Glycosaminoglycan sulodexide modulates inflammatory pathways in chronic venous disease. , 2014, International angiology : a journal of the International Union of Angiology.

[19]  R. Kirsner,et al.  Elevated Levels of Coagulation Factor VIII in Patients With Venous Leg Ulcers , 2014, The international journal of lower extremity wounds.

[20]  Hong Zhang,et al.  RETRACTED ARTICLE: Molecular basis underlying inhibition of metastasis of gastric cancer by anti-VEGFa treatment , 2014, Tumor Biology.

[21]  K. Kohama,et al.  Platelet-derived growth factor-BB induces matrix metalloproteinase-2 expression and rat vascular smooth muscle cell migration via ROCK and ERK/p38 MAPK pathways , 2014, Molecular and Cellular Biochemistry.

[22]  E. Zubkova,et al.  Urokinase Stimulates Production of Matrix Metalloproteinase-9 in Fibroblasts with Involvement of Reactive Oxygen Species , 2014, Bulletin of Experimental Biology and Medicine.

[23]  J. Raffetto,et al.  Pathophysiology of chronic venous disease. , 2014, International angiology : a journal of the International Union of Angiology.

[24]  A. Munari,et al.  [Medical significance of endothelial glycocalyx. Part 2: Its role in vascular diseases and in diabetic complications]. , 2014, Archivos de cardiologia de Mexico.

[25]  P. Secchiero,et al.  Modulation of Circulating Cytokine-Chemokine Profile in Patients Affected by Chronic Venous Insufficiency Undergoing Surgical Hemodynamic Correction , 2014, Journal of immunology research.

[26]  M. Hecker,et al.  Pathogenesis of varicose veins - lessons from biomechanics. , 2014, VASA. Zeitschrift fur Gefasskrankheiten.

[27]  N. Uriel,et al.  Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation. , 2014, European heart journal.

[28]  D. Longrois,et al.  Decreased PGE2 Content Reduces MMP-1 Activity and Consequently Increases Collagen Density in Human Varicose Vein , 2014, PloS one.

[29]  D. Agrawal,et al.  MMP‐1 and MMP‐9 regulate epidermal growth factor‐dependent collagen loss in human carotid plaque smooth muscle cells , 2014, Physiological reports.

[30]  A. Frati-Munari,et al.  [Medical significance of endothelial glycocalyx]. , 2013, Archivos de cardiologia de Mexico.

[31]  J. Raffetto,et al.  Glycosaminoglycan sulodexide inhibition of MMP-9 gelatinase secretion and activity: possible pharmacological role against collagen degradation in vascular chronic diseases. , 2013, Current vascular pharmacology.

[32]  R. Khalil,et al.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins. , 2013, Current drug targets.

[33]  J. Raffetto.  Inflammation in chronic venous ulcers , 2013, Phlebology.

[34]  Jennifer H. Shin,et al.  Heparan Sulfate Regrowth Profiles Under Laminar Shear Flow Following Enzymatic Degradation , 2013, Cellular and molecular bioengineering.

[35]  Lena Blomgren,et al.  Parameter der Koagulation und Fibrinolyse bei Patienten mit chronischer venöser Insuffizienz , 2013 .

[36]  G. Gambaro,et al.  A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition , 2012, Journal of Translational Medicine.

[37]  J. Szecsenyi,et al.  Varicose veins are a risk factor for deep venous thrombosis in general practice patients. , 2012, VASA. Zeitschrift fur Gefasskrankheiten.

[38]  R. Launois,et al.  Construction and international validation of CIVIQ-14 (a short form of CIVIQ-20), a new questionnaire with a stable factorial structure , 2012, Quality of Life Research.

[39]  J. Shalhoub,et al.  The Effect of Pressure-Induced Mechanical Stretch on Vascular Wall Differential Gene Expression , 2012, Journal of Vascular Research.

[40]  P. Secchiero,et al.  Endothelial Cells Obtained from Patients Affected by Chronic Venous Disease Exhibit a Pro-Inflammatory Phenotype , 2012, PloS one.

[41]  A. Davies,et al.  Increased activation of the hypoxia-inducible factor pathway in varicose veins. , 2012, Journal of vascular surgery.

[42]  H. Atta.  Varicose Veins: Role of Mechanotransduction of Venous Hypertension , 2012, International journal of vascular medicine.

[43]  D. Laukens,et al.  Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[44]  H. Lipowsky.  The Endothelial Glycocalyx as a Barrier to Leukocyte Adhesion and Its Mediation by Extracellular Proteases , 2011, Annals of Biomedical Engineering.

[45]  M. Hecker,et al.  Experimental hypertension triggers varicosis‐like maladaptive venous remodeling through activator protein‐1 , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  A. Połubińska,et al.  Sulodexide reduces senescence-related changes in human endothelial cells , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[47]  S. Lehoux,et al.  Characterization of the Differential Response of Endothelial Cells Exposed to Normal and Elevated Laminar Shear Stress , 2011, Journal of cellular physiology.

[48]  H. H. Lipowsky,et al.  Composition of the endothelial glycocalyx and its relation to its thickness and diffusion of small solutes. , 2010, Microvascular research.

[49]  M. Ma,et al.  Mechanosensitive transient receptor potential vanilloid type 1 channels contribute to vascular remodeling of rat fistula veins. , 2010, Journal of vascular surgery.

[50]  P. Delafontaine,et al.  Interleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-kappaB activation. , 2010, American journal of physiology. Heart and circulatory physiology.

[51]  J. Raffetto,et al.  MMP-2 induced vein relaxation via inhibition of [Ca2+]e-dependent mechanisms of venous smooth muscle contraction. Role of RGD peptides. , 2010, The Journal of surgical research.

[52]  A. Davies,et al.  Prolonged mechanical stretch is associated with upregulation of hypoxia-inducible factors and reduced contraction in rat inferior vena cava. , 2010, Journal of vascular surgery.

[53]  M. Myśliwiec,et al.  Effect of Sulodexide on Plasma Transforming Growth Factor-β1 in Healthy Volunteers , 2010, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[54]  G. Nash,et al.  A role for the endothelial glycosaminoglycan hyaluronan in neutrophil recruitment by endothelial cells cultured for prolonged periods , 2009, Experimental cell research.

[55]  A. Davies,et al.  Pathogenesis of primary varicose veins , 2009, The British journal of surgery.

[56]  Ying Lin,et al.  In vitro differences between smooth muscle cells derived from varicose veins and normal veins. , 2009, Journal of vascular surgery.

[57]  A. Mulivor,et al.  Inhibition of Glycan Shedding and Leukocyte‐Endothelial Adhesion in Postcapillary Venules by Suppression of Matrixmetalloprotease Activity with Doxycycline , 2009, Microcirculation.

[58]  H. Ogawa,et al.  Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. , 2009, Journal of the American College of Cardiology.

[59]  W. Marston,et al.  Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy. , 2009, Journal of vascular surgery.

[60]  A. Połubińska,et al.  Sulodexide suppresses inflammation in human endothelial cells and prevents glucose cytotoxicity. , 2009, Translational research : the journal of laboratory and clinical medicine.

[61]  H. Vidrio,et al.  Endothelial Function Impairment in Chronic Venous Insufficiency: Effect of Some Cardiovascular Protectant Agents , 2009, Angiology.

[62]  J. Tarlton,et al.  The relationship between cytokine concentrations and wound healing in chronic venous ulceration. , 2008, Journal of vascular surgery.

[63]  J. Raffetto,et al.  Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: Potential implications in varicose veins. , 2008, Journal of vascular surgery.

[64]  Young-Chae Chang,et al.  Tanshinone IIA from Salvia miltiorrhiza BUNGE inhibits human aortic smooth muscle cell migration and MMP‐9 activity through AKT signaling pathway , 2008, Journal of cellular biochemistry.

[65]  J. Raffetto,et al.  Mechanisms of varicose vein formation: valve dysfunction and wall dilation , 2008, Phlebology.

[66]  K. C. Overman,et al.  Mitogen-Activated Protein Kinase p38 Pathway in Venous Ulcer Fibroblasts , 2008, Vascular and endovascular surgery.

[67]  J. Tekoppele,et al.  Effect of collagen turnover and matrix metalloproteinase activity on healing of venous leg ulcers , 2008, The British journal of surgery.

[68]  J. Raffetto,et al.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. , 2008, Biochemical pharmacology.

[69]  A. Połubińska,et al.  Anti-Inflammatory Effect of Sulodexide during Acute Peritonitis in Rats , 2008, Blood Purification.

[70]  J. Naoum,et al.  Pathogenesis of Varicose Veins and Implications for Clinical Management , 2007, Vascular.

[71]  P. Wiedemann,et al.  Positive feedback regulation between MMP-9 and VEGF in human RPE cells. , 2007, Investigative ophthalmology & visual science.

[72]  A. Lescanic,et al.  Shedding of the Endothelial Glycocalyx in Arterioles, Capillaries and Venules , 2007, American journal of physiology. Heart and circulatory physiology.

[73]  G. Pascual,et al.  TGF-β1 Upregulation in the Aging Varicose Vein , 2007, Journal of Vascular Research.

[74]  J. Raffetto,et al.  Matrix metalloproteinase 2-induced venous dilation via hyperpolarization and activation of K+ channels: relevance to varicose vein formation. , 2007, Journal of vascular surgery.

[75]  G. Godeau,et al.  Comparison of extracellular matrix in skin and saphenous veins from patients with varicose veins: does the skin reflect venous matrix changes? , 2007, Clinical science.

[76]  M. Knaapen,et al.  The Histopathology of Varicose Vein Disease , 2006, Angiology.

[77]  G. Schmid-Schönbein,et al.  Chronic venous disease. , 2006, The New England journal of medicine.

[78]  J. Constans,et al.  Circulating markers of endothelial function in cardiovascular disease. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[79]  Gloria Avalos,et al.  The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers. , 2006, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[80]  G. Belcaro,et al.  Circulating Endothelial Cells in Venous Blood as a Marker of Endothelial Damage in Chronic Venous Insufficiency: Improvement with Venoruton , 2006, Journal of cardiovascular pharmacology and therapeutics.

[81]  J. Raffetto,et al.  Mitogen-Activated Protein Kinase Pathway Regulates Cell Proliferation in Venous Ulcer Fibroblasts , 2006, Vascular and endovascular surgery.

[82]  J. Fabiani,et al.  Decreased Production of Collagen Type III in Cultured Smooth Muscle Cells from Varicose Vein Patients Is due to a Degradation by MMPs: Possible Implication of MMP-3 , 2005, Journal of Vascular Research.

[83]  J. Beebe-Dimmer,et al.  The epidemiology of chronic venous insufficiency and varicose veins. , 2005, Annals of epidemiology.

[84]  T. Jacob,et al.  Overexpression of transforming growth factor-beta1 correlates with increased synthesis of nitric oxide synthase in varicose veins. , 2005, Journal of Vascular Surgery.

[85]  R. Khalil,et al.  Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction. , 2004, Journal of vascular surgery.

[86]  G. Schmid-Schönbein,et al.  Venous hypertension, inflammation and valve remodeling. , 2004, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[87]  P. Ganz,et al.  Role of Endothelial Dysfunction in Atherosclerosis , 2004, Circulation.

[88]  A. Mulivor,et al.  Inflammation- and ischemia-induced shedding of venular glycocalyx. , 2004, American journal of physiology. Heart and circulatory physiology.

[89]  O. Topolcan,et al.  Bioimpedance Analysis and Assessment of Intracellular Water in Peritoneal Dialysis Patients , 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[90]  S. Verma,et al.  New Markers of Inflammation and Endothelial Cell Activation: Part I , 2003, Circulation.

[91]  M. Stacey,et al.  Cytokines and growth factors in keratinocytes and sweat glands in chronic venous leg ulcers. An immunohistochemical study , 2003, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[92]  J. Spaan,et al.  Endothelial Cell Glycocalyx Modulates Immobilization of Leukocytes at the Endothelial Surface , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[93]  G. Hunter,et al.  Morphologic characteristics of varicose veins: possible role of metalloproteinases. , 2003, Journal of vascular surgery.

[94]  Amir Lerman,et al.  Endothelial Dysfunction: A Marker of Atherosclerotic Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[95]  M. Idzko,et al.  Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane‐type matrix metalloproteinases in venous leg ulcers , 2002, The British journal of dermatology.

[96]  A. Mulivor,et al.  Role of glycocalyx in leukocyte-endothelial cell adhesion. , 2002, American journal of physiology. Heart and circulatory physiology.

[97]  N. Rich,et al.  Varicose veins possess greater quantities of MMP-1 than normal veins and demonstrate regional variation in MMP-1 and MMP-13. , 2002, The Journal of surgical research.

[98]  J. Michel,et al.  Plasma Matrix Metalloproteinase-9 as a Marker of Blood Stasis in Varicose Veins , 2002, Circulation.

[99]  J. Fabiani,et al.  Synthesis of Collagen Is Dysregulated in Cultured Fibroblasts Derived From Skin of Subjects With Varicose Veins as It Is in Venous Smooth Muscle Cells , 2002, Circulation.

[100]  Cynthia Cohen,et al.  Reactive oxygen generated by Nox1 triggers the angiogenic switch , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[101]  M. Stacey,et al.  Mitogenic activity and cytokine levels in non‐healing and healing chronic leg ulcers , 2001, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[102]  J. Fabiani,et al.  Imbalance in the Synthesis of Collagen Type I and Collagen Type III in Smooth Muscle Cells Derived from Human Varicose Veins , 2001, Journal of Vascular Research.

[103]  A. Siegbahn,et al.  Coagulation and fibrinolysis in chronic venous insufficiency. , 2001, VASA. Zeitschrift fur Gefasskrankheiten.

[104]  J. Michel,et al.  Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study , 2001, The Journal of pathology.

[105]  B. Duling,et al.  TNF-α increases entry of macromolecules into luminal endothelial cell glycocalyx , 2000 .

[106]  A. Nicolaides,et al.  Investigation of chronic venous insufficiency: A consensus statement (France, March 5-9, 1997). , 2000, Circulation.

[107]  J. Norgauer,et al.  Plasminogen activation in venous leg ulcers , 2000, The British journal of dermatology.

[108]  F. Dignat-George,et al.  Circulating endothelial cells in vascular disorders: new insights into an old concept , 2000, European journal of haematology.

[109]  M. Jacob,et al.  Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation , 2000, The Journal of pathology.

[110]  G. Schmid-Schönbein,et al.  Expression of Adhesion Molecules and Cytokines on Saphenous Veins in Chronic Venous Insufficiency , 2000, Annals of vascular surgery.

[111]  W. Wahl,et al.  Changes in the extracellular matrix of the vein wall--the cause of primary varicosis? , 2000 .

[112]  A. Morla,et al.  Control of smooth muscle cell proliferation and phenotype by integrin signaling through focal adhesion kinase. , 2000, Biochemical and biophysical research communications.

[113]  P. Weismann,et al.  The determination of the collagen and elastin amount in the human varicose vein by the computer morphometric method. , 1999, General physiology and biophysics.

[114]  P. Smith.  Neutrophil Activation and Mediators of Inflammation in Chronic Venous Insufficiency , 1999, Journal of Vascular Research.

[115]  G. Schmid-Schönbein,et al.  Leukocyte activation in patients with venous insufficiency. , 1999, Journal of vascular surgery.

[116]  M. Knaapen,et al.  Vascular Remodeling in Varicose Veins , 1998, Angiology.

[117]  W. Giannobile,et al.  Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial Mechanisms , 1998, Advances in dental research.

[118]  P. Coleridge-Smith,et al.  Increased plasma vascular endothelial growth factor among patients with chronic venous disease. , 1998, Journal of vascular surgery.

[119]  J. Scurr,et al.  Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease. , 1997, Journal of vascular surgery.

[120]  R. Launois,et al.  Construction and validation of a quality of life questionnaire in Chronic Lower Limb Venous Insufficiency (CIVIQ) , 1996, Quality of Life Research.

[121]  H. Sato,et al.  v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. , 1993, The Journal of biological chemistry.

[122]  M. D. Tilson,et al.  Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins. , 1993, Journal of vascular surgery.

[123]  A. Nicolaides,et al.  Venous wall function in the pathogenesis of varicose veins. , 1992, Surgery.

[124]  J. Raffetto,et al.  Sulodexide down-regulates the release of cytokines, chemokines, and leukocyte colony stimulating factors from human macrophages: role of glycosaminoglycans in inflammatory pathways of chronic venous disease. , 2014, Current vascular pharmacology.

[125]  J. Tarbell,et al.  Interstitial flow induces MMP-1 expression and vascular SMC migration in collagen I gels via an ERK1/2-dependent and c-Jun-mediated mechanism. , 2010, American journal of physiology. Heart and circulatory physiology.

[126]  A. J. White,et al.  Attenuates Myocardial Ischemia / Reperfusion Injury and the Deposition of C-Reactive Protein in Areas of Infarction without Affecting Hemostasis , 2004 .

[127]  G. Schmid-Schönbein,et al.  Monocyte infiltration into venous valves. , 1998, Journal of vascular surgery.